Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial The Lancet Nawigacja wpisu Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 | NEJM – nejm.org Internal Medicine Physicians Supportive of Executive Order on Reproductive Health, But More Needed to Restore Rights | ACP Newsroom | ACP – American College of Physicians
